Immunocore Holdings (IMCR) Income from Continuing Operations (2023 - 2025)
Historic Income from Continuing Operations for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to -$196000.0.
- Immunocore Holdings' Income from Continuing Operations fell 10224.36% to -$196000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.3 million, marking a year-over-year increase of 3783.2%. This contributed to the annual value of -$51.1 million for FY2024, which is 759.67% up from last year.
- Per Immunocore Holdings' latest filing, its Income from Continuing Operations stood at -$196000.0 for Q3 2025, which was down 10224.36% from -$10.3 million recorded in Q2 2025.
- Immunocore Holdings' Income from Continuing Operations' 5-year high stood at $8.7 million during Q3 2024, with a 5-year trough of -$52.6 million in Q4 2021.
- Its 5-year average for Income from Continuing Operations is -$17.6 million, with a median of -$17.2 million in 2022.
- Per our database at Business Quant, Immunocore Holdings' Income from Continuing Operations skyrocketed by 86423.84% in 2024 and then plummeted by 10224.36% in 2025.
- Quarter analysis of 5 years shows Immunocore Holdings' Income from Continuing Operations stood at -$52.6 million in 2021, then surged by 66.87% to -$17.4 million in 2022, then dropped by 13.24% to -$19.7 million in 2023, then decreased by 20.48% to -$23.8 million in 2024, then surged by 99.18% to -$196000.0 in 2025.
- Its last three reported values are -$196000.0 in Q3 2025, -$10.3 million for Q2 2025, and $5.0 million during Q1 2025.